Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p65
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 65/66)
Character Range: 213932–217132

mg
omit from the column headed "Brand": Karvea
[436] Schedule 5, entry for Itraconazole
omit from the column headed "Brand": APO-Itraconazole
[437] Schedule 5, entry for Macrogol 3350
omit from the column headed "Brand": Movicol
[438] Schedule 5, entries for Naloxone
omit:
Naloxone  GRP-27818  Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2         Nasal  Nyxoid
Naloxone  GRP-27818  Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2 (s19A)  Nasal  Nyxoid (UK)

[439] Schedule 5, omit entries Nifedipine
[440] Schedule 5, entry for Pantoprazole in the form Tablet (enteric coated) 20 mg (as sodium sesquihydrate)
insert in alphabetical order in the column headed "Brand": APX-PANTOPRAZOLE
[441] Schedule 5, entry for Pioglitazone in the form Tablet 45 mg (as hydrochloride)
(a) omit from the column headed "Brand": Acpio 45
(b) omit from the column headed "Brand": Actaze
[442] Schedule 5, entry for Pioglitazone in the form Tablet 15 mg (as hydrochloride)
(a) omit from the column headed "Brand": Acpio 15
(b) omit from the column headed "Brand": Actaze

[443] Schedule 5, entry for Pioglitazone in the form Tablet 30 mg (as hydrochloride)
(a) omit from the column headed "Brand": Acpio 30
(b) omit from the column headed "Brand": Actaze
(c) insert in alphabetical order in the column headed "Brand": ARX-PIOGLITAZONE
[444] Schedule 5, entry for Quetiapine in each of the forms: Tablet 300 mg (as fumarate); Tablet 200 mg (as fumarate); Tablet 100 mg (as fumarate); and Tablet 25 mg (as fumarate)
insert in alphabetical order in the column headed "Brand": QUETIAPINE-WGR
[445] Schedule 5, entry for Quinapril in the form Tablet 20 mg (as hydrochloride)
omit:
Quinapril  GRP-19716  Tablet 20 mg (as hydrochloride)  Oral  Accupril
                                                             ACQUIN
                                                             APO-Quinapril

[446] Schedule 5, entry for Quinapril in the form Tablet 10 mg (as hydrochloride)
omit:
Quinapril  GRP-19902  Tablet 10 mg (as hydrochloride)  Oral  Accupril
                                                             ACQUIN
                                                             APO-Quinapril

[447] Schedule 5, entry for Riluzole
omit from the column headed "Brand": APO-Riluzole
[448] Schedule 5, entries for Timolol
substitute:
Timolol  GRP-29229  Eye drops 5 mg (as maleate) per mL, 5 mL                                                 Application to the eye  Timoptol
Timolol  GRP-29229  Eye drops 5 mg (as maleate) per mL, 5 mL (S19A)                                          Application to the eye  Timolol (Brown & Burk, UK)
Timolol  GRP-28880  Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL                         Application to the eye  Timoptol XE
Timolol  GRP-28880  Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL (S19A)                  Application to the eye  Timoptol XE 0.50% (South Africa)
Timolol  GRP-28880  Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL - (Timoptol-LA) (S19A)  Application to the eye  Timoptol-LA 0.5 % (Santen Oy, Finland)

[449] Schedule 5, entry for Valaciclovir